More on SRRK

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+6.7% Growth)
- Ratings (9.5 Score)

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Scholar Rock Holding Corp. (NQ:SRRK)
Delayed: 41.49 -0.47 (1.12%)
Prev. Close $41.96  
Open$41.58 
52 Wk High$ 
52 Wk Low$ 
Day High$41.95 
Day Low$40.76 
P/E N/A  
EPS$ 
Volume1,207,203 

Friends, Peers and Foes (?): OWL, REGN, RHHBY, MARA OLMA (more...)

Oct 20, 2026 09:24 AM Truist Securities Reiterates Buy Rating on Scholar Rock (SRRK) After KOL Feedback
Oct 20, 2026 08:00 AM Scholar Rock to Report Third Quarter 2026 Financial Results on November 10, 2026
Oct 18, 2026 08:00 PM U.S. biotech SMids: Q3 earnings preview
Oct 16, 2026 04:15 PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 13, 2026 09:03 AM Truist Securities Reiterates Buy Rating on Scholar Rock (SRRK)
Oct 8, 2026 09:51 AM Raymond James Reiterates Strong Buy Rating on Scholar Rock (SRRK)
Oct 8, 2026 08:01 AM Scholar Rock resubmits SMA drug application to European regulators
Oct 8, 2026 08:00 AM Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (MAA) to European Medicines Agency (EMA) for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
Oct 1, 2026 04:20 PM Form 144 Scholar Rock Holding Filed by: Peng Katie
Sep 25, 2026 04:12 PM Form 4 Scholar Rock Holding For: Sep 24 Filed by: Woods Keith
View All Articles

Entities mentioned with SRRK

View All Entities